PL3496730T3 - Egzosomy pochodzące z komórek mezenchymalnych do leczenia zaburzeń neurologicznych - Google Patents
Egzosomy pochodzące z komórek mezenchymalnych do leczenia zaburzeń neurologicznychInfo
- Publication number
- PL3496730T3 PL3496730T3 PL17841210.2T PL17841210T PL3496730T3 PL 3496730 T3 PL3496730 T3 PL 3496730T3 PL 17841210 T PL17841210 T PL 17841210T PL 3496730 T3 PL3496730 T3 PL 3496730T3
- Authority
- PL
- Poland
- Prior art keywords
- neurological disorders
- mesenchymal cell
- derived exosomes
- treat neurological
- treat
- Prior art date
Links
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
- 210000004027 cell Anatomy 0.000 title 1
- 210000001808 exosome Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662374852P | 2016-08-14 | 2016-08-14 | |
| PCT/IL2017/050899 WO2018033911A1 (en) | 2016-08-14 | 2017-08-14 | Mesenchymal cell-derived exosomes to treat neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3496730T3 true PL3496730T3 (pl) | 2022-09-26 |
Family
ID=61196484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17841210.2T PL3496730T3 (pl) | 2016-08-14 | 2017-08-14 | Egzosomy pochodzące z komórek mezenchymalnych do leczenia zaburzeń neurologicznych |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11129852B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3496730B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7014449B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109843305B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017311684B2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2925527T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL264825B (cg-RX-API-DMAC7.html) |
| PL (1) | PL3496730T3 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201901272WA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018033911A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210005031A (ko) | 2018-03-29 | 2021-01-13 | 테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디. | Pten 억제제를 포함하는 소포 및 이의 용도 |
| AU2019341538B2 (en) * | 2018-09-20 | 2023-04-20 | Citospin, S.L. | Method for obtaining an enriched population of functional mesenchymal stem cells, cells obtained thereof and compositions comprising the same |
| AU2020303456A1 (en) | 2019-06-26 | 2022-02-17 | Technion Research And Development Foundation Limited | Production of extracellular vesicles from stem cells |
| JP6830286B1 (ja) | 2020-06-26 | 2021-02-17 | デクソンファーマシューティカルズ株式会社 | 精巣機能改善剤および精巣機能改善方法 |
| EP4183866A4 (en) | 2020-07-17 | 2024-08-28 | Dexon Pharmaceuticals Inc. | Composition, binding inhibitor, medical device, and method for preventing covid-19 |
| US20230321152A1 (en) | 2020-09-08 | 2023-10-12 | Dexon Pharmaceuticals Inc. | Cytokine storm suppressor, method for using cytokine storm suppressor and screening method |
| JP6974892B1 (ja) | 2021-05-27 | 2021-12-01 | デクソンファーマシューティカルズ株式会社 | 癌悪液質の改善剤および癌悪液質の改善方法 |
| JP7492757B2 (ja) | 2022-03-22 | 2024-05-30 | Ｄｅｘｏｎファーマシューティカルズ株式会社 | 遺伝子の発現制御剤、アルツハイマー病の予防薬または治療薬および認知症の改善方法 |
| WO2023223312A1 (en) | 2022-05-15 | 2023-11-23 | Nurexone Biologic Ltd. | Anti-pten rna interference oligonucleotides and uses thereof |
| CN115006427A (zh) * | 2022-05-31 | 2022-09-06 | 尧舜泽生物医药(南京)有限公司 | 骨髓间充质干细胞外泌体在治疗帕金森病中的应用 |
| WO2023248844A1 (ja) | 2022-06-20 | 2023-12-28 | Ｄｅｘｏｎファーマシューティカルズ株式会社 | Ｈｍｇｂ１の発現制御剤；急性肺損傷、急性呼吸窮迫症候群または敗血症の予防薬または治療薬、あるいはそれらの改善方法 |
| WO2023248845A1 (ja) | 2022-06-20 | 2023-12-28 | Ｄｅｘｏｎファーマシューティカルズ株式会社 | Ｐｔｘ３の発現制御剤；関節リウマチ、自己免疫疾患に伴う血管炎または皮膚硬化の予防薬または治療薬、あるいはそれらの改善方法 |
| CN120078807A (zh) * | 2025-02-08 | 2025-06-03 | 广东省人民医院 | 改善卵巢功能的MSC-sEVs药物及其制备方法和应用 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| KR20070110087A (ko) * | 2005-02-23 | 2007-11-15 | 알자 코포레이션 | 중추신경계에 활성 약제의 비강 투여 |
| WO2008036374A2 (en) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogeneic stem cell transplants in non-conditioned recipients |
| US20110014251A1 (en) | 2008-01-04 | 2011-01-20 | Lydac Neuroscience Limited | Microvesicles |
| JP5718648B2 (ja) | 2008-02-22 | 2015-05-13 | エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ（エイ・スター） | 間葉系幹細胞粒子 |
| KR20100054711A (ko) | 2008-11-14 | 2010-05-25 | 메디포스트(주) | 간엽 줄기세포 또는 이의 배양액을 포함하는 신경질환의 예방 또는 치료용 조성물 |
| JP5667180B2 (ja) * | 2009-07-01 | 2015-02-12 | イオン メディックス インコーポレイテッド | 哺乳類の有核細胞に由来するマイクロベシクル及びその用途 |
| ES2663330T3 (es) | 2010-03-26 | 2018-04-12 | Tokushima University | Composición para el tratamiento de una parte dañada |
| JP5608927B2 (ja) | 2010-04-13 | 2014-10-22 | 国立大学法人名古屋大学 | 歯髄幹細胞を用いた神経疾患治療用組成物 |
| GB201011589D0 (en) | 2010-07-09 | 2010-08-25 | Reneuron Ltd | Therapeutic cells |
| JP2013537538A (ja) * | 2010-08-13 | 2013-10-03 | ザ ユニバーシティ コート オブ ザ ユニバーシティ オブ グラスゴー | 微小水泡および関連するマイクロｒｎａの治療用途 |
| US9574173B2 (en) * | 2010-11-15 | 2017-02-21 | Accelerated Biosciences Corp. | Generation of neural stem cells from human trophoblast stem cells |
| EP2709636A2 (en) * | 2011-05-19 | 2014-03-26 | Ariel-University Research and Development Company Ltd. | Use of mesenchymal stem cells for the improvement of affective and cognitive function |
| US10034902B2 (en) * | 2012-02-22 | 2018-07-31 | Exostem Biotec Ltd. | MicroRNAs for the generation of astrocytes |
| KR101993027B1 (ko) | 2012-04-03 | 2019-09-30 | 레뉴런 리미티드 | 줄기 세포 마이크로입자 |
| WO2013186735A2 (en) | 2012-06-14 | 2013-12-19 | Bar-Ilan Research And Development Company Ltd. | Photothermal detection |
| US20160220613A1 (en) * | 2013-09-16 | 2016-08-04 | Agency For Science, Technology And Research | Method |
| WO2016149358A1 (en) | 2015-03-16 | 2016-09-22 | Duncan Ross | Method of treatment comprising membrane-enclosed vesicle |
-
2017
- 2017-08-14 PL PL17841210.2T patent/PL3496730T3/pl unknown
- 2017-08-14 US US16/325,445 patent/US11129852B2/en active Active
- 2017-08-14 SG SG11201901272WA patent/SG11201901272WA/en unknown
- 2017-08-14 EP EP17841210.2A patent/EP3496730B1/en active Active
- 2017-08-14 CN CN201780063347.2A patent/CN109843305B/zh active Active
- 2017-08-14 WO PCT/IL2017/050899 patent/WO2018033911A1/en not_active Ceased
- 2017-08-14 ES ES17841210T patent/ES2925527T3/es active Active
- 2017-08-14 JP JP2019508178A patent/JP7014449B2/ja active Active
- 2017-08-14 IL IL264825A patent/IL264825B/en unknown
- 2017-08-14 AU AU2017311684A patent/AU2017311684B2/en active Active
-
2021
- 2021-08-04 US US17/394,008 patent/US20210361717A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210361717A1 (en) | 2021-11-25 |
| EP3496730A1 (en) | 2019-06-19 |
| WO2018033911A1 (en) | 2018-02-22 |
| CA3033951A1 (en) | 2018-02-22 |
| AU2017311684A1 (en) | 2019-03-07 |
| IL264825A (cg-RX-API-DMAC7.html) | 2019-04-30 |
| AU2017311684B2 (en) | 2023-05-04 |
| US11129852B2 (en) | 2021-09-28 |
| SG11201901272WA (en) | 2019-03-28 |
| US20190209621A1 (en) | 2019-07-11 |
| ES2925527T3 (es) | 2022-10-18 |
| AU2017311684A2 (en) | 2019-03-28 |
| JP7014449B2 (ja) | 2022-02-01 |
| EP3496730B1 (en) | 2022-05-25 |
| JP2019524824A (ja) | 2019-09-05 |
| EP3496730A4 (en) | 2020-05-06 |
| CN109843305B (zh) | 2023-03-10 |
| CN109843305A (zh) | 2019-06-04 |
| IL264825B (en) | 2022-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3496730T3 (pl) | Egzosomy pochodzące z komórek mezenchymalnych do leczenia zaburzeń neurologicznych | |
| ZA201901279B (en) | Compositions and methods for treatment of neurological disorders | |
| IL285151B1 (en) | Methods for the treatment of fgf21-related disorders | |
| IL273693A (en) | Treatment of inflammatory disorders | |
| IL259147A (en) | Exosomes derived from mesenchymal stem cells and their uses | |
| GB201402070D0 (en) | Pharmaceutical compositions for the treatment of inflammatory disorders | |
| IL262348A (en) | Preparations for the treatment of excessive radiation disorders | |
| SG11201701377YA (en) | Compositions and methods to treat vision disorders | |
| PT3119911T (pt) | Compostos para uso no tratamento da doença de alzheimer em pacientes apoe4+/+ | |
| SG11201609993YA (en) | Treatment of immune disorders | |
| GB201412578D0 (en) | Treatment of neurological diseases | |
| PL3432895T3 (pl) | Lizat osadu płytek krwi do stosowania w leczeniu zaburzeń neurologicznych | |
| SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
| GB201612043D0 (en) | Composition for treatment of disorders | |
| PL3200828T3 (pl) | Kompozycje donosowe do leczenia chorób i zaburzeń neurologicznych i neurodegeneracyjnych | |
| GB2516138B (en) | The treatment of inflammatory disorders | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| LT3458067T (lt) | Neurologinių sutrikimų gydymas | |
| PL3377089T3 (pl) | Kompozycje zawierające cdnf do zastosowania do donosowego leczenia chorób ośrodkowego układu nerwowego | |
| EP3245215A4 (en) | Methods of treating neurological inflammatory disorders | |
| TWI561235B (en) | Increase of protein synthesis ameliorates synaptopathy-related neurological disorders | |
| EP3215178A4 (en) | Treatment of cns inflammatory disorders | |
| HK40066377A (zh) | 治疗神经疾病的组合物和方法 | |
| SG11201706952VA (en) | Compositions and methods for the treatment of epilepsy and neurological disorders | |
| PT3420084T (pt) | Nova abordagem para tratamento de disfunções inflamatórias |